Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 11:46 PM
Study NCT ID:
NCT01945294
Status:
COMPLETED
Last Update Posted:
2018-07-12
First Post:
2013-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-10
Start Date Type:
ACTUAL
Primary Completion Date:
2015-08-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-13
First Submit QC Date:
None
Study First Post Date:
2013-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-07-27
Results First Submit QC Date:
None
Results First Post Date:
2016-11-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-14
Last Update Post Date:
2018-07-12
Last Update Post Date Type:
ACTUAL